This federal contract award is for the procurement of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, by the Defense Logistics Agency (DLA) from the prime contractor Amerisourcebergen Drug Corp. The contract has a ceiling value of $6,666.38 and is a Firm Fixed Price Delivery Order that runs through December 6, 2024.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely a delivery order placed against that larger IDC.
The contract does not have a set-aside designation, indicating open competition. This order for ELIQUIS 5 MG TABLET 60S supports the provision of essential pharmaceutical products to federal healthcare beneficiaries, including military personnel and veterans.
Generated 3/6/25, 10:07 AM